Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - ramipril - tablets - ramipril 2.5 mg - ramipril - ramipril - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : - hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) - high total cholesterol (>5.2 mmol/l) - low hdl ( <0.9 mmol/l) - current smoker - known microalbuminuria - clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - tablets - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - tablets - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - tablets - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - tablets - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

United States - English - NLM (National Library of Medicine)

directrx - ramipril (unii: l35jn3i7sj) (ramiprilat - unii:6n5u4qfc3g) - ramipril 10 mg - - 1.1 hypertension ramipril capsules are indicated for the treatment of hypertension. they may be used alone or in combination with thiazide diuretics. 1.3 heart failure post-myocardial infarction ramipril capsules are indicated in stable patients who have demonstrated clinical signs of congestive heart failure within the first few days after sustaining acute myocardial infarction. administration of ramipril capsules to such patients has been shown to decrease the risk of death (principally cardiovascular death) and to decrease the risks of failure-related hospitalization and progression to severe/resistant heart failure [see clinical studies ( 14.3)]. ramipril capsules are indicated for the treatment of hypertension. they may be used alone or in combination with thiazide diuretics. ramipril capsules are indicated in stable patients who have demonstrated clinical signs of congestive heart failure within the first few days after sustaining acute myocardial infarction. administration of ram

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - ramipril -

United States - English - NLM (National Library of Medicine)

northwind pharmaceuticals - ramipril (unii: l35jn3i7sj) (ramiprilat - unii:6n5u4qfc3g) - ramipril 5 mg - hypertension ramipril capsules usp are indicated for the treatment of hypertension. it may be used alone or in combination with thiazide diuretics. heart failure post-myocardial infarction ramipril capsules usp are indicated in stable patients who have demonstrated clinical signs of congestive heart failure within the first few days after sustaining acute myocardial infarction. administration of ramipril to such patients has been shown to decrease the risk of death (principally cardiovascular death) and to decrease the risks of failure-related hospitalization and progression to severe/resistant heart failure [see clinical studies (14.3)]. ramipril is contraindicated in patients who are hypersensitive to this product or any other ace inhibitor (e.g., a patient who has experienced angioedema during therapy with any other ace inhibitor). 8.1 pregnancy pregnancy category d use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and inc

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - ramipril -

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - ramipril -